Compare · TRNS vs VLTO
TRNS vs VLTO
Side-by-side comparison of Transcat Inc. (TRNS) and Veralto Corp (VLTO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both TRNS and VLTO operate in Electrical Products (Industrials), so they compete in similar markets.
- VLTO is the larger of the two at $22.15B, about 27.1x TRNS ($818.7M).
- Over the past year, TRNS is up 8.2% and VLTO is down 12.1% - TRNS leads by 20.2 points.
- VLTO has been more active in the news (16 items in the past 4 weeks vs 1 for TRNS).
- VLTO has more recent analyst coverage (19 ratings vs 8 for TRNS).
- Company
- Transcat Inc.
- Veralto Corp
- Price
- $88.11+1.82%
- $90.17-3.25%
- Market cap
- $818.7M
- $22.15B
- 1M return
- -4.98%
- +7.36%
- 1Y return
- +8.18%
- -12.07%
- Industry
- Electrical Products
- Electrical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- 2023
- News (4w)
- 1
- 16
- Recent ratings
- 8
- 19
Transcat Inc.
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, oil and gas and alternative energy, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.
Latest TRNS
- Transcat to Host First Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, August 4, 2026 at 4:30 p.m. Eastern Time
- SEC Form 4 filed by Chief Strat. & CorpDev Officer Simmons Royal Thomas Jr.
- SEC Form 3 filed by new insider Simmons Royal Thomas Jr.
- Transcat Announces Appointment of Roy Simmons as Chief Strategy and Corporate Development Officer
- SEC Form 4 filed by Chief Information Officer Haddad Michael Jacques
- Chief Operating Officer West Michael W. was granted 1,051 shares and covered exercise/tax liability with 465 shares, increasing direct ownership by 2% to 27,086 units (SEC Form 4) (for withholding tax)
- SEC Form 4 filed by Principal Accounting Officer Johnston Kristina L
- Chief Human Resources Officer Conroy Theresa A. was granted 759 shares and covered exercise/tax liability with 335 shares, increasing direct ownership by 22% to 2,361 units (SEC Form 4) to cover withholding tax
- Sr. VP Finance & CFO Barbato Thomas L was granted 1,719 shares and covered exercise/tax liability with 760 shares, increasing direct ownership by 26% to 4,649 units (SEC Form 4) (tax withholding)
- SEC Form 4 filed by President and CEO Irick Jaime A
Latest VLTO
- President and CEO Honeycutt Jennifer sold $674,215 worth of shares (7,097 units at $95.00) as part of a pre-agreed trading plan and exercised 7,097 shares at a strike of $28.76 (SEC Form 4)
- Veralto Acquires Alfaa UV to Expand Ultraviolet Water Treatment Portfolio
- Director Schwieters John T was granted 1,009 shares, increasing direct ownership by 18% to 6,498 units (SEC Form 4)
- Director Williams Thomas was granted 1,009 shares, increasing direct ownership by 43% to 3,380 units (SEC Form 4)
- Director Wallis-Lage Cindy L. was granted 1,009 shares, increasing direct ownership by 43% to 3,380 units (SEC Form 4)
- Director Sankaran Vijay P. was granted 1,009 shares, increasing direct ownership by 61% to 2,669 units (SEC Form 4)
- Director Mitts Heath A was granted 1,009 shares, increasing direct ownership by 41% to 3,500 units (SEC Form 4)
- Director Lohr Walter G was granted 1,009 shares, increasing direct ownership by 43% to 3,380 units (SEC Form 4)
- Director King William was granted 1,009 shares, increasing direct ownership by 12% to 9,557 units (SEC Form 4)
- Director Kambeyanda Shyam was granted 1,099 shares, increasing direct ownership by 46% to 3,470 units (SEC Form 4)